DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Symbiotec Pharmalab Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·17 Sept 2026, 1:38 pm

Symbiotec Pharmalab

Symbiotec Pharmalab Limited has informed stock exchanges about its upcoming meeting with analysts and institutional investors. This announcement signals that the company is preparing to discuss its future strategy, financial performance, or business developments with the investment community.

For investors, such meetings provide an opportunity to understand the management's perspective on market conditions and growth plans. It helps in gauging the company's direction and can offer insights into upcoming catalysts that might influence the stock price.

Investors should watch for any specific updates or guidance shared during the meeting. While the event itself is informational, the content discussed can be a key factor in evaluating the company's prospects and making informed investment decisions.